IRCT201701131556N94招募中2 期
Saffron versus Methylphenidate in the treatment of Attention Deficit/ Hyperactivity Disorder: a double-blind and randomized trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 years 至 17 years（—）
- 性别
- All
入选标准
- •diagnosis of ADHD based on DSM-5; age between 6-17 years old.
- •Exclusion criteria: Intellectual disability; presence of any psychiatric disorders except for ODD; history of allergy to saffron or Ritaline; presence of any medical problem including cardiovascular diseases; presence of uncontrolled seizures; systolic blood pressure more than 120 mm Hg; resting pulse rate less than 60/minute or more than 115/minute; receiving warfarin, ASA and other antiplatelete agents; receiving any herbal medicine including fever few, garlic, ginseng, dong quai, and red clover; 14 days before any surgery; nursing and pregnancy
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Saffron versus fluoxetine for depression in post-PCI patientsMajor Depression.IRCT201202281556N36Tehran University of Medical Sciences50
已完成
2 期
Comparison of effect of Saffron versus memantine in patients with severe Alzheimer's diseaseAlzheimer's disease.IRCT201203051556N39Tehran University of Medical Sciences50
已完成
不适用
Efficacy of saffron as an adjunct treatment for unremitted depression in adultsDepressionACTRN12618000748213Murdoch University160
已完成
3 期
Saffron in the treatment of post-partum depressioPost partum depression.Mental and behavioural disorders associated with the puerperium, not elsewhere classifiedIRCT201509201556N82Tehran University of Medical Sciences50
招募中
2 期
Comparing the effect of saffron extract with methylphenidate in hyperactivity disorderIRCT20101130005280N63Mashhad University of Medical Sciences60